Lakefront Biotherapeutics N.V.
LKFT | NASDAQ
$32.05
-$0.23 (-0.71%)
Nov 2, 2026, 11:02 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 |
|---|---|---|---|---|---|
Net Income | 2.11M | 14.49M | 782.15M | -202.11M | -105.75M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | -35.44M | -813.79M | -57.83M | -57.21M |
Other Non-Cash Items | -2.11M | -61.8M | -15.82M | 197.33M | 54.18M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -35.44M | -813.79M | -57.83M | -57.21M |
Operating Cash Flow | n/a | -82.75M | -47.46M | -62.61M | -108.78M |
Capital Expenditures | n/a | -123K | -1.6M | -2.85M | -4.16M |
Cash Acquisitions | n/a | 2.34M | 1.62M | 8.08M | -22.19M |
Purchase of Investments | n/a | -51.18M | -413.22M | -964.34M | -1.75B |
Sales Maturities Of Investments | n/a | 109.14M | 480.37M | 1B | 1.82B |
Other Investing Acitivies | n/a | 1.32M | 5.46M | 13.11M | 23.84M |
Investing Cash Flow | n/a | 61.5M | 72.62M | 56.74M | 74.71M |
Debt Repayment | n/a | -510K | -405K | -1.26M | -600K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | n/a | -510K | -405K | -1.26M | -600K |
Net Cash Flow | -66.81M | -21.06M | 23.41M | -7.21M | -36.4M |
Free Cash Flow | n/a | -82.87M | -49.07M | -65.46M | -112.94M |
Adj. Free Cash Flow | n/a | -82.87M | -49.07M | -65.46M | -112.94M |
Maintenance CapEx | n/a | n/a | n/a | -2.42M | -4.16M |
Growth CapEx | n/a | -123K | -1.6M | -433.82K | n/a |
Owner Earnings | n/a | -82.75M | -47.46M | -65.02M | -112.94M |
Add to Watchlist
Select watchlists to add or remove LKFT